Summary
Определение
Анамнез и осмотр
Ключевые диагностические факторы
- medication error in infants
- witnessed ingestion or child found with empty bottle or pill
- history of deliberate ingestion
- history of substance misuse
- sympathomimetic toxidrome
- antimuscarinic toxidrome
- opioid toxidrome
- sedative-hypnotic toxidrome
- cholinergic toxidrome
Другие диагностические факторы
- nausea, vomiting, or diarrhea
- altered mental status
- fever or hyperthermia
- staining or burns of the mouth and oropharynx
- hypertension or hypotension
- hyperventilation or hypoventilation
- seizures
- blindness or reduced vision
- reduced hearing or tinnitus
- reddened skin coloration
- symptoms and signs of hypoglycemia
- jaundice
- hyperreflexia and myoclonus
- muscle rigidity
- nystagmus
- ataxia
- stridor
Факторы риска
- presence of medications in the household
- easy access to medications or household chemicals
- young age
- pica
- emotional stress
- history of depression or other mental illness
- female sex
- family history of alcohol use disorder
Диагностические исследования
Исследования, которые показаны в первую очередь
- serum electrolytes
- serum BUN
- serum creatinine
- fingerstick or serum glucose
- capillary blood gas or ABG
- anion gap
- serum lactate
- serum ketones or acetone
- INR
- LFTs
- serum acetaminophen levels
- serum salicylate levels
- urine drug screen
- urinalysis
- ECG
- pregnancy test
- serum creatine kinase
- abdominal x-ray
- chest x-ray
Tests to avoid
- hair or nail testing
Исследования, проведение которых нужно рассмотреть
- ethanol level
- serum methanol or ethylene glycol
- serum digoxin level
- serum anticonvulsant levels
- serum iron levels
- serum lithium, theophylline, or whole blood heavy metal levels
- comprehensive urine drug screen
- therapeutic trial of naloxone
- therapeutic trial of sodium bicarbonate
- therapeutic trial of atropine and pralidoxime
- therapeutic trial of flumazenil
- therapeutic trial of octreotide
- therapeutic trial of physostigmine
Алгоритм лечения
asymptomatic
symptomatic and/or high-risk ingestion and/or elevated drug levels
Составители
Авторы
David L. Eldridge, MD
Associate Professor of Pediatrics
Senior Associate Dean of Academic Affairs
Brody School of Medicine at East Carolina University
Greenville
NC
Раскрытие информации
DLE has received research grants and been a site investigator for a closed clinical trial from GlaxoSmithKline and a closed clinical trial from Cempra Pharmaceuticals. DLE is an author of two of the references cited in this topic.
Matthew R. Ledoux, MD
Chair, Department of Pediatrics
Pediatrician in Chief Maynard Children's Hospital
Associate Professor of Pediatrics
Maynard Distinguished Scholar of Pediatrics
Brody School of Medicine at East Carolina University
ECU Health
Greenville
NC
Раскрытие информации
MRL declares that he has no competing interests.
Выражение благодарностей
Dr David Eldridge and Dr Matthew Ledoux would like to gratefully acknowledge Dr Cynthia K. Aaron and Dr Keenan M. Bora, previous contributors to this topic.
Раскрытие информации
CKA and KMB declare that they have no competing interests.
Рецензенты
Laurie Prescott, MD, FRCP
Emeritus Professor of Clinical Pharmacology
Faculty of Medicine
University of Edinburgh
Edinburgh
UK
Раскрытие информации
LP declares that he has no competing interests.
Mark Mannenbach, MD
Consultant in Pediatric Emergency Medicine
Assistant Professor of Pediatric and Adolescent Medicine
Mayo Clinic College of Medicine
Rochester
MN
Раскрытие информации
MM declares that he has no competing interests.
Colin A. Graham, MBChB, MPH, MD, FRCSEd, FRCSGlasg, FIMCRCSEd, FCCP, FCEM, FHKCEM, FHKAM
Editor
European Journal of Emergency Medicine
Professor of Emergency Medicine
Chinese University of Hong Kong
Hong Kong
People's Republic of China
Раскрытие информации
CAG is the editor of the European Journal of Emergency Medicine and receives an annual honorarium from Wolters Kluwer Health, the journal's publishers.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Список литературы
Основные статьи
Hoffman RS, Burns MM, Gosselin S. Ingestion of caustic substances. N Engl J Med. 2020 Apr 30;382(18):1739-48.
McKay C. Can the laboratory help me? Toxicology laboratory testing in the possibly poisoned pediatric patient. Clin Pedi EM. 2005;6:116-22.
Dart RC, Goldfrank LR, Erstad BL, et al. Expert consensus guidelines for stocking of antidotes in hospitals that provide emergency care. Ann Emerg Med. 2018 Mar;71(3):314-25.e1.Полный текст Аннотация
Royal College of Emergency Medicine. College of Emergency Medicine and National Poisons Information Service guideline on antidote availability for emergency departments, 2021 update. Dec 2021 [internet publication].Полный текст
American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. Position paper: single-dose activated charcoal. Clin Toxicol (Phila). 2005;43(2):61-87.Полный текст Аннотация
Статьи, указанные как источники
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Отличия
- Nontoxic causes of wide complex tachycardia
- Nontoxic causes of status epilepticus
- Nontoxic causes of anion gap metabolic acidosis
Больше ОтличияРекомендации
- Expert consensus for a national essential antidote list: e-Delphi method
- Guideline on antidote availability for emergency departments
Больше РекомендацииВойдите в учетную запись или оформите подписку, чтобы получить полноценный доступ к BMJ Best Practice
Использование этого контента попадает под действие нашего заявления об отказе от ответственности